Cargando…

A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use

BACKGROUND: Limited data exist regarding how medications for pediatric use can be developed to minimize medication errors. The integrase inhibitor raltegravir was developed for use in neonates (≥2 kg). Anticipating that neonatal administration would be performed primarily by mothers with varying deg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Alexander, Myers, Laurie, Raudenbush, Casey, Vossen, David A., Teppler, Hedy, Miteva, Yanna R., Seeley, Suzanne, Homony, Brenda, Straus, Walter L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	HIV Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658952/ https://www.ncbi.nlm.nih.gov/pubmed/34694252 http://dx.doi.org/10.1097/INF.0000000000003334

Ejemplares similares

1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
por: Teppler, Hedy, et al.
Publicado: (2014)

886. Pregnancy Outcomes Following Raltegravir Exposure
por: Shamsuddin, Hala, et al.
Publicado: (2019)

Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure
por: Jacobs, Tom G., et al.
Publicado: (2022)

Evaluation of Neural Tube Defects (NTDs) After Exposure to Raltegravir During Pregnancy
por: Shamsuddin, Hala, et al.
Publicado: (2019)

Long-Term Safety from the Raltegravir Clinical Development Program
por: Teppler, Hedy, et al.
Publicado: (2011)

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
por: Lommerse, Jos, et al.
Publicado: (2019)

Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial
por: Cahn, Pedro, et al.
Publicado: (2018)

Assessing knowledge, acceptability and social implications of a peer-to-peer HIV self-testing kit distribution model among adolescents aged 15–24 in Zambia and Uganda—HISTAZU: a mixed-method study protocol
por: Ssemata, Andrew Sentoogo, et al.
Publicado: (2022)

Effectiveness of self-testing kits availability on improving HIV testing frequency for chinese men who have sex with men and their sexual partners: a protocol for a multicenter randomised controlled trial
por: Zhang, Ci, et al.
Publicado: (2018)

Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies
por: Squires, Kathleen, et al.
Publicado: (2017)

Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): is it acceptable to young people living with HIV?
por: Bernays, Sarah, et al.
Publicado: (2017)

Mobility study of young women who exchange sex for money or commodities using Google Maps and qualitative methods in Kampala, Uganda
por: King, Rachel, et al.
Publicado: (2021)

HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study
por: Lima, Yanna Andressa Ramos, et al.
Publicado: (2016)

Optimising HIV care using information obtained from PROMs: protocol for an observational study
por: Moody, Kevin, et al.
Publicado: (2023)

Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study
por: Aboud, M, et al.
Publicado: (2010)

Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi*
por: MacPherson, Peter, et al.
Publicado: (2012)

THE INFLUENCE OF HIV-1 SUBTYPES C, CRF31_BC AND B ON DISEASE PROGRESSION AND INITIAL VIROLOGIC RESPONSE TO HAART IN A SOUTHERN BRAZILIAN COHORT
por: Nunes, Cynara Carvalho, et al.
Publicado: (2014)

DETERMINATION OF VIRAL TROPISM BY GENOTYPING AND PHENOTYPING ASSAYS IN BRAZILIAN HIV-1-INFECTED PATIENTS
por: Arruda, Liã Bárbara, et al.
Publicado: (2014)

Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in India
por: Alvarez-Uria, Gerardo
Publicado: (2014)

DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME
por: SOARES, Lismeia Raimundo, et al.
Publicado: (2015)

PRETERM BIRTH AND FETAL GROWTH RESTRICTION IN HIV-INFECTED BRAZILIAN PREGNANT WOMEN
por: dos REIS, Helena Lucia Barroso, et al.
Publicado: (2015)

A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
por: Nakagawa, Fumiyo, et al.
Publicado: (2016)

Harm reduction interventions in HIV care: a qualitative exploration of patient and provider perspectives
por: Carlberg-Racich, Suzanne
Publicado: (2016)

A pilot study to evaluate the magnitude of association of the use of electronic personal health records with patient activation and empowerment in HIV-infected veterans
por: Crouch, Pierre-Cédric B., et al.
Publicado: (2015)

Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007
por: Biraro, Samuel, et al.
Publicado: (2013)

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
por: Lofano, Giuseppe, et al.
Publicado: (2018)

Mortality in HIV-infected patients with tuberculosis treated with streptomycin and a two-week intensified regimen: data from an HIV cohort study using inverse probability of treatment weighting
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2016)

Older adults at high risk of HIV infection in China: a systematic review and meta-analysis of observational studies
por: Wang, Yuan Yuan, et al.
Publicado: (2020)

HIV and the eye
por: Gichuhi, Stephen, et al.
Publicado: (2020)

Clusters of sub-Saharan African countries based on sociobehavioural characteristics and associated HIV incidence
por: Merzouki, Aziza, et al.
Publicado: (2021)

Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long‐Term Antiretroviral Suppressive Therapy (EVERLAST) Study
por: Sarfo, Fred Stephen, et al.
Publicado: (2021)

Estimated blood pressure trajectories and hypertension patterns among pregnant women living with HIV, Haiti, 2007–2017
por: Tymejczyk, Olga, et al.
Publicado: (2022)

Investigation of discriminatory attitude toward people living with HIV in the family context using socio-economic factors and information sources: A nationwide study in Indonesia
por: Nursalam, Nursalam, et al.
Publicado: (2022)

A community health worker delivered intervention to address hypertension among adults engaged in HIV care in northern Tanzania: Outcomes from a pilot feasibility study
por: Manavalan, Preeti, et al.
Publicado: (2022)

What interventions are effective in improving uptake and retention of HIV-positive pregnant and breastfeeding women and their infants in prevention of mother to child transmission care programmes in low-income and middle-income countries? A systematic review and meta-analysis
por: Puchalski Ritchie, Lisa M, et al.
Publicado: (2019)

Raltegravir monohydrate
por: Yamuna, Thammarse S., et al.
Publicado: (2013)

Motor activation in literal and non-literal sentences: does time matter?
por: Cacciari, Cristina, et al.
Publicado: (2013)

Music and the Brain, Literally
por: LeDoux, Joseph
Publicado: (2011)

Cluster randomised controlled trial to determine the effect of peer delivery HIV self-testing to support linkage to HIV prevention among young women in rural KwaZulu-Natal, South Africa: a study protocol
por: Adeagbo, Oluwafemi Atanda, et al.
Publicado: (2019)

Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection
por: Amin, Janaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fgv956os1cmmqicht2bqnjqqum